• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏转甲状腺素蛋白淀粉样变患者右心室起搏的有害影响:心脏再同步治疗的潜在临床益处。

Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy.

作者信息

Aouate David, Menet Aymeric, Bellevre Dimitri, Damy Thibaud, Marechaux Sylvestre

机构信息

Cardiology Department, GCS-Groupement des Hôpitaux de l'Institut Catholique Lillois/Faculté de médecine et de maïeutique, UCLille, F-59000 Lille, France.

Department of Nuclear Medicine, UF 5881, Groupement des Hôpitaux de l'Institut Catholique de Lille, Hôpital Saint Philibert rue du grand but, 59160 Lomme, France.

出版信息

Eur Heart J Case Rep. 2020 May 1;4(3):1-5. doi: 10.1093/ehjcr/ytaa088. eCollection 2020 Jun.

DOI:10.1093/ehjcr/ytaa088
PMID:32617488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7319833/
Abstract

BACKGROUND

Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing.

CASES SUMMARY

We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT).

DISCUSSION

The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation.

摘要

背景

心脏淀粉样变性累及与不良预后相关,包括频繁心律失常、心力衰竭和传导障碍,可能需要永久起搏。

病例总结

我们报告两例转甲状腺素蛋白淀粉样变性(ATTR)患者,在永久性右心室(RV)起搏后发生心力衰竭且左心室射血分数(LVEF)降低,但对心脏再同步治疗(CRT)反应良好。

讨论

RV起搏和CRT对心脏淀粉样变性的影响尚不清楚。在我们的病例中,永久性RV起搏介导的功能和左心室功能下降以及CRT后左心室收缩功能障碍逆转伴QRS波宽度减小提示永久性RV起搏对左心室(LV)收缩功能和心力衰竭症状有不良影响。对于无论LVEF如何都需要心室起搏的ATTR患者是否应立即推荐心脏再同步治疗值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/301b3f8b75b8/ytaa088f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/1664e7c1365b/ytaa088f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/20cdf7c2fd4f/ytaa088f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/b589fbaddee3/ytaa088f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/a6003a46fe10/ytaa088f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/301b3f8b75b8/ytaa088f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/1664e7c1365b/ytaa088f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/20cdf7c2fd4f/ytaa088f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/b589fbaddee3/ytaa088f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/a6003a46fe10/ytaa088f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956a/7319833/301b3f8b75b8/ytaa088f5.jpg

相似文献

1
Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy.心脏转甲状腺素蛋白淀粉样变患者右心室起搏的有害影响:心脏再同步治疗的潜在临床益处。
Eur Heart J Case Rep. 2020 May 1;4(3):1-5. doi: 10.1093/ehjcr/ytaa088. eCollection 2020 Jun.
2
Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality.转甲状腺素蛋白淀粉样变心肌病患者的心脏装置:对心功能分级、左心室功能、二尖瓣反流和死亡率的影响。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2427-2432. doi: 10.1111/jce.14180. Epub 2019 Sep 25.
3
Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.右室间隔部起搏作为心脏再同步治疗候选者中左心室起搏导线植入失败的替代方法。
Europace. 2015 Jan;17(1):94-100. doi: 10.1093/europace/euu259. Epub 2014 Oct 30.
4
Cardiac resynchronization therapy in patients with heart failure and narrow QRS complexes (≤ 130 ms): role of speckle tracking echocardiography and different interventricular (VV) pacing intervals.心力衰竭伴窄 QRS 波群(≤130ms)患者的心脏再同步治疗:斑点追踪超声心动图和不同的室间(VV)起搏间期的作用。
J Interv Card Electrophysiol. 2022 Mar;63(2):369-377. doi: 10.1007/s10840-021-01021-y. Epub 2021 Jun 17.
5
Cardiac resynchronization therapy (CRT) with right ventricular sense triggered left ventricular pacing benefits for the hemodynamics compared with standard CRT for chronic congestive heart failure: A cross-over study.与标准心脏再同步治疗(CRT)相比,右心室感知触发左心室起搏的心脏再同步治疗对慢性充血性心力衰竭患者的血流动力学有益:一项交叉研究。
Cardiol J. 2015;22(1):80-6. doi: 10.5603/CJ.a2014.0058. Epub 2014 Sep 2.
6
Left ventricular-only pacing in heart failure patients with normal atrioventricular conduction improves global function and left ventricular regional mechanics compared with biventricular pacing: an adaptive cardiac resynchronization therapy sub-study.左心室-only 起搏在房室传导正常的心力衰竭患者中改善整体功能和左心室节段力学,优于双心室起搏:适应性心脏再同步治疗亚研究。
Eur J Heart Fail. 2017 Oct;19(10):1335-1343. doi: 10.1002/ejhf.906. Epub 2017 Jun 26.
7
RV electrical activation in heart failure during right, left, and biventricular pacing.心力衰竭时右、左和双心室起搏的 RV 电激活。
JACC Cardiovasc Imaging. 2010 Jun;3(6):567-75. doi: 10.1016/j.jcmg.2009.12.017.
8
Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.左心室与双心室起搏对逆向重构影响的比较:心力衰竭再同步治疗评估研究(EARTH 试验)的相关见解。
Can J Cardiol. 2017 Oct;33(10):1274-1282. doi: 10.1016/j.cjca.2017.07.478. Epub 2017 Jul 31.
9
Remote past left ventricular function before chronic right ventricular pacing predicts responses to cardiac resynchronization therapy upgrade.慢性右心室起搏前的既往左心室功能可预测心脏再同步治疗升级的反应。
Pacing Clin Electrophysiol. 2014 Apr;37(4):454-63. doi: 10.1111/pace.12291. Epub 2013 Nov 19.
10
Left ventricular electrical activation during right ventricular pacing in heart failure patients with LBBB: visualization by electrocardiographic imaging and implications for cardiac resynchronization therapy.左束支传导阻滞心力衰竭患者右心室起搏时的左心室电激活:通过心电图成像可视化及对心脏再同步治疗的意义
J Electrocardiol. 2015 Jan-Feb;48(1):53-61. doi: 10.1016/j.jelectrocard.2014.09.002. Epub 2014 Sep 16.

本文引用的文献

1
Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality.转甲状腺素蛋白淀粉样变心肌病患者的心脏装置:对心功能分级、左心室功能、二尖瓣反流和死亡率的影响。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2427-2432. doi: 10.1111/jce.14180. Epub 2019 Sep 25.
2
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.他法米地用于治疗遗传性转甲状腺素蛋白淀粉样多神经病的长期安全性和有效性:长达6年的结果
Amyloid. 2017 Sep;24(3):194-204. doi: 10.1080/13506129.2017.1357545. Epub 2017 Jul 31.
3
Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
转甲状腺素蛋白和 AL 型心脏淀粉样变性预后标志物的鉴定。
Amyloid. 2016 Sep;23(3):194-202. doi: 10.1080/13506129.2016.1221815. Epub 2016 Sep 20.
4
Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis.心脏淀粉样变性患者接受合适的植入式心脏复律除颤器治疗的结果及发生率
Int J Cardiol. 2016 Nov 1;222:562-568. doi: 10.1016/j.ijcard.2016.07.254. Epub 2016 Aug 1.
5
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
6
Cardiac amyloidosis: updates in diagnosis and management.心脏淀粉样变性:诊断与治疗进展。
Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23.
7
Cardiac resynchronization therapy in a patient with amyloid cardiomyopathy.
Acta Cardiol. 2013 Jun;68(3):335-7. doi: 10.1080/ac.68.3.2983432.
8
Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.对严重心脏淀粉样变性且有心脏性猝死高风险的患者进行心脏复律除颤器的预防性植入。
Heart Rhythm. 2008 Feb;5(2):235-40. doi: 10.1016/j.hrthm.2007.10.016. Epub 2007 Oct 9.